ALDX (Aldeyra Therapeutics) Cyclically Adjusted Book per Share: $2.45 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALDX Aldeyra Therapeutics Inc ALDX
30 GF Score
Price $1.52
! 1 Warning Sign
View Full Analysis

What is Aldeyra Therapeutics Cyclically Adjusted Book per Share?

Aldeyra Therapeutics ALDX 30 Cyclically Adjusted Book per Share is $2.45 as of Jun. 2026. GuruFocus rates ALDX with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Aldeyra Therapeutics's adjusted book value per share for the three months ended in Jun. 2026 was $0.628. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.45 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Aldeyra Therapeutics's average Cyclically Adjusted Book Growth Rate was -7.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Aldeyra Therapeutics was 14.60% per year. The lowest was 14.60% per year. And the median was 14.60% per year.

As of today (2026-08-12), Aldeyra Therapeutics's current stock price is $1.52. Aldeyra Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $2.45. Aldeyra Therapeutics's Cyclically Adjusted PB Ratio of today is 0.62.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Aldeyra Therapeutics was 0.62. The lowest was 0.00. And the median was 0.00.


Aldeyra Therapeutics  (NAS:ALDX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Aldeyra Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.52/2.45
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Aldeyra Therapeutics was 0.62. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Aldeyra Therapeutics Cyclically Adjusted Book per Share Related Terms


Aldeyra Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Aldeyra Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aldeyra Therapeutics Cyclically Adjusted Book per Share Chart

Aldeyra Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.66 2.39 2.71 2.50

Aldeyra Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.64 2.58 2.50 2.49 2.45

ALDX vs NTHI, BMEA, PTHS: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Aldeyra Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aldeyra Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aldeyra Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aldeyra Therapeutics's Cyclically Adjusted PB Ratio falls into.


ALDX
30GF Score
Aldeyra Therapeutics Inc ALDX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aldeyra Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aldeyra Therapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.628/333.9520*333.9520
=0.628

Current CPI (Jun. 2026) = 333.9520.

Aldeyra Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201609 2.042 241.428 2.825
201612 1.722 241.432 2.382
201703 1.850 243.801 2.534
201706 1.541 244.955 2.101
201709 2.401 246.819 3.249
201712 2.069 246.524 2.803
201803 1.831 249.554 2.450
201806 1.774 251.989 2.351
201809 1.362 252.439 1.802
201812 3.300 251.233 4.387
201903 2.916 254.202 3.831
201906 2.495 256.143 3.253
201909 1.874 256.759 2.437
201912 1.678 256.974 2.181
202003 1.473 258.115 1.906
202006 1.600 257.797 2.073
202009 1.790 260.280 2.297
202012 1.539 260.474 1.973
202103 2.646 264.877 3.336
202106 4.029 271.696 4.952
202109 3.784 274.310 4.607
202112 3.542 278.802 4.243
202203 3.271 287.504 3.799
202206 2.985 296.311 3.364
202209 2.770 296.808 3.117
202212 2.579 296.797 2.902
202303 2.334 301.836 2.582
202306 2.209 305.109 2.418
202309 2.078 307.789 2.255
202312 2.024 306.746 2.204
202403 1.909 312.332 2.041
202406 1.655 314.175 1.759
202409 1.429 315.301 1.514
202412 1.190 315.605 1.259
202503 1.059 319.799 1.106
202506 0.921 322.561 0.954
202509 0.819 324.800 0.842
202512 0.736 324.054 0.758
202603 0.699 330.213 0.707
202606 0.628 333.952 0.628

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $2.45 mean?
Aldeyra Therapeutics (ALDX) has a Cyclically Adjusted Book per Share of $2.45 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Aldeyra Therapeutics and its competitors.
Is Aldeyra Therapeutics' Cyclically Adjusted Book per Share too high?
Aldeyra Therapeutics' current Cyclically Adjusted Book per Share is $2.45. Overall, Aldeyra Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Aldeyra Therapeutics' Cyclically Adjusted Book per Share compare to NTHI and BMEA?
Aldeyra Therapeutics' Cyclically Adjusted Book per Share of $2.45 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Aldeyra Therapeutics and its competitors. Aldeyra Therapeutics's current Cyclically Adjusted Book per Share is $2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aldeyra Therapeutics stock overvalued right now?
Aldeyra Therapeutics (ALDX) has a current Cyclically Adjusted Book per Share of $2.45. The current Cyclically Adjusted Book per Share is $2.45. Aldeyra Therapeutics' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Aldeyra Therapeutics (ALDX), the current Cyclically Adjusted Book per Share is $2.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aldeyra Therapeutics Business Description

Other Exchanges 137:Germany
Address 131 Hartwell Avenue, Suite 320, Lexington, MA, USA, 02421
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
30GF Score

Get the complete analysis for ALDX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price